Literature DB >> 31489683

Discussion of Schuemie et al: "A plea to stop using the case-control design in retrospective database studies".

Sebastian Schneeweiss1, Samy Suissa2.   

Abstract

Mesh：

Year:  2019        PMID： 31489683     DOI： 10.1002/sim.8320

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  6 in total

1.  Emulating a target trial in case-control designs: an application to statins and colorectal cancer.

Authors:  Barbra A Dickerman; Xabier García-Albéniz; Roger W Logan; Spiros Denaxas; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2020-10-01       Impact factor: 7.196

2.  Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework.

Authors:  Sizheng Steven Zhao; Houchen Lyu; Daniel H Solomon; Kazuki Yoshida
Journal:  Ann Rheum Dis       Date:  2020-05-07       Impact factor: 19.103

3.  Association of injury after prescription opioid initiation with risk for opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study.

Authors:  Yu-Jung Jenny Wei; Cheng Chen; Ting-Yuan David Cheng; Siegfried O Schmidt; Roger B Fillingim; Almut G Winterstein
Journal:  PLoS Med       Date:  2022-09-22       Impact factor: 11.613

Review 4.  Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case-control study designs.

Authors:  Anton Pottegård
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-06-07       Impact factor: 2.732

Review 5.  Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design.

Authors:  Marco Trevisan; Edouard L Fu; Yang Xu; Kitty Jager; Carmine Zoccali; Friedo W Dekker; Juan Jesus Carrero
Journal:  Clin Kidney J       Date:  2020-12-14

6.  Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.

Authors:  Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 19.871
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.